Back to search

Finland· FI-REL-REL60687

Comirnaty Original/Omicron BA.4-5

A covid-19, rna-based vaccine product containing tozinameran + famtozinameran, registered in Finland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedComirnaty Original/Omicron BA.4-5ATCJ07BN01REGISTER NO.FI-REL-REL60687PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Tozinameran + Famtozinameran
Manufacturer
BioNTech Manufacturing GmbH
Country
Finland (FI)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Covid-19, rna-based vaccine in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1b914707-694b-4b31-bbe5-fb70da14e319
GET /v1/drugs/1b914707-694b-4b31-bbe5-fb70da14e319?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, dispersio",
  "route": "Lihakseen",
  "ddd_unit": null,
  "strength": "15/15 mikrog/annos",
  "atc_label": "COVID-19-rokotteet, RNA-pohjaiset",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/20/1528/008-009,014",
  "fimea_rel_id": "REL60687",
  "authorised_at": "2022-09-12"
}

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.